越秀資本(000987.SZ):廣州資產擬不超2.04億元買入越秀地產港股股票
格隆匯7月1日丨越秀資本(000987.SZ)公佈,公司於2025年7月1日召開第十屆董事會第二十四次會議和第十屆監事會第二十次會議,審議通過《關於控股子公司廣州資產增持越秀地產股份暨關聯交易的議案》,同意公司控股子公司廣州資產管理有限公司(簡稱“廣州資產”)使用不超過2.0422億元(不含交易費用;幣種爲人民幣,下同)的自有資金,通過港股通在二級市場買入越秀地產股份有限公司(簡稱“越秀地產”)港股股票。鑑於越秀地產現有部分股東爲公司關聯方,本次交易屬於與關聯方共同投資,構成關聯交易,本事項在公司董事會決策權限範圍內。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.